Financials

Discussions Technicals Seasonals

005690 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMICELL operating, investing, and financing activities

005690 free cash flow for Q3 24 is 5.42 B KRW. For 2023, 005690 free cash flow was 5.8 B KRW and operating cash flow was 11.81 B KRW.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—